Author: Marcus Essing

PZ and DAZ shine a spotlight on the master’s study program “Regulatory Affairs and Drug Development” for its 5th anniversary

The study program “Regulatory Affairs and Drug Development” was introduced in the winter of 2018 and hence just celebrated its 5th anniversary. On this occasion, an overview article about the study program was published in “Pharmazeutische Zeitung”. In addition, the journal “Deutsche Apothekerzeitung” conducted and published an interview with Dr. Anja Langeneckert and Dr. Anna Resch about the study program.

Further information on the masters’s program “Regulatory Affairs and Drug Development” on LinkedIn and the website of the Pharmaceutical Institute of the University of Freiburg.

 

Competiton of Ideas

In 2023 we organized a competiton at the student’s level to generate innovative teaching ideas using AI-Tools. As this was a very successful project a new competition is launched during the summer semester of 2024:

Theme for the 2024 ideas competition has been decided
This year’s competition revolves around the “Value of Work.” Why do we work? What values and goals does each individual associate with studying, working, or further education? We are eager to learn which ideas students connect with these questions. Please find full announcement for this year’s competition here. (text so far only in German).

In addition to a prize of € 500, it is foreseen to implement successful contributions in consultation with the “winners”.

 

Statement

Our association “academia meets industry” supports on open democratic and tolerant society. We ask our members to strongly defend these values and principles of our democracy at any time.

Andreas Bechthold, Helmut Laaff, Friederike Zahm

 

Netzwerk-Stipendium: Invitation to apply for a scholarship program

Academia Meets Industry (AMI) is an organization in support of pharmacy students at the University of Freiburg, Germany. There is an increasing awareness that pharmacy students who are interested in job perspectives in the pharma industry should be connected to this industry as early as possible during their studies.

In this context, AMI offers a “Netzwerkstipendium” to support students within Pharmaceutical Sciences (Master or Staatsexamen) and doctoral researchers at the pharmaceutical institute of the University of Freiburg.

The students within this program will be in close contact with an executive mentor working in the pharmaceutical industry. This person will provide advice to the student, make contacts for them and support them in their career planning. In addition AMI will grant 100€ per month as financial support covering for individual expenses.

Students and doctoral researchers at the faculty of pharmaceutical sciences especially those with an interest in drug development and regulatory affairs are eligible for this program. Participants will be chosen by our organization on an individual basis.

Written application including a vita should not exceed 2 pages. The application (PDF-file) should be sent to . Please also send a printed version to Prof. Dr. Andreas Bechthold, Universität Freiburg, Institut für Pharmazeutische Wissenschaften, Stefan-Meier-Str. 19, 79104 Freiburg

Deadline of application is 11.11.2024.

 

Master student Isabelle Roux rewarded by the German association for market access

In 2022, the German association for market access, Deutsche Fachgesellschaft für Market Access e.V., rewarded Isabelle Roux, one of our Master students for her Master thesis: Auswirkungen der bedingten Zulassung von Medikamenten auf die Erstattung in der EU.

This is an excellent example for the quality and high topicality of the Master theses within our program. Congrats to Isabelle!

 

The Phoenix Pharmacy Science Award 2021 at the Category Pharmaceutical Biology was awarded to Prof. Dr. A. Bechthold and his Research Group.

The research group is thus awarded for its outstanding work and publication “Secondary nucleotide messenger c-di-GMP exerts a global control on natural product biosynthesis in streptomycetes” in the journal “Nucleic Acid Research“, carried out by Dr. Roman Makitrynskyy, Olga Tsypik, Desirée Nuzzo of the working group in cooperation with Dr. Thomas Paululat, head of NMR facilities and research associate at the University of Siegen, and Prof. Dr. David L. Zechel, Department of Chemistry, Queen’s University, Kingston, Ontario, Canada under the direction of Prof. Dr. Andreas Bechthold.

 

Master’s program “Regulatory Affairs & Drug Development

At the winter semester and in further study years, there will be another opportunity to enroll in the unique Master’s program “Regulatory Affairs & Drug Development” at the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg. It is best to register with your study coordinator as soon as possible using this form.

Watch this video to find a short introduction into the study program.

You can find even more information about the master’s program via this recording of an information event about the master profile line from Mai of 2021. The recording also starts with the previous introduction video.

Interview with Prof. Dr. Andreas Bechthold, Executive Director of the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)

Interview with Prof. Dr. Helmut Laaff , CEO – Institut für Dermatohistology, Pathology, Molecular Pathology, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)

Interview with Daniela Dietz, Head of Regulatory ad Dr. Regenold GmbH, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)

Video Testimonials of (former) Students of the Master’s Program “Regulatory Affairs & Drug Development”